Conclusions of a national multicenter intercomparative study of in vitro cultures of human hematopoietic progenitors

Bone Marrow Transplantation

Volumn 23, Issue 4, 1999, Pages 373-380

  Lamana, M ^a,d   Albella, B ^a   Rodriguez F ^b   Regidor, C ^c   Bueren, J A ^a  

^a CIEMAT   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Clonogenic cultures; Hematopoietic progenitors; Multicentric intercomparison; Standardization

Indexed keywords

ARTICLE; BURST FORMING UNIT E; CELL CULTURE; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MONONUCLEAR CELL; PRIORITY JOURNAL; SCORING SYSTEM; STANDARDIZATION; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

EID: 0032967813     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701577     Document Type: Article

References (33)

1. Bradley T, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med 1966; 44: 2287-2300.
2. Pike B, Robinson W. Human bone marrow colony growth in agar gel. J Cell Physiol 1970; 76: 77-84.
3. Spitzer G, Verna D, Fisher R et al. The myeloid progenitor cell. Its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 1980; 55: 317-323.
4. Schlunk T, Ruber E, Schleyer M. Survival of bone marrow progenitor cells after freezing: improved detection in the colony formation assays. Cryobiol 1981; 18: 111-118.
5. Healy L, Nirsimloo N, Scolt M et al. In vitro proliferation by cells mobilized into the peripheral blood for collection and autologous transplantation. Exp Hematol 1984; 22: 1278-1282.
6. To L, Dyson P, Juttner C. Cell dose effect in circulating stem cell autografting. Lancet 1986; ii: 404-411.
7. Douay L, Gorin N, Mary J et al. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 1986; 14: 358-365.
8. Jones R, Sharkis S, Celano P et al. Progenitor cell assays predict hematopoietic reconstitution after syngenic transplantation in mice. Blood 1987; 70: 1186-1191.
9. Boye Hansen P, Knudsen H, Gaarsdal E et al. Short-term in vivo priming of bone marrow haematopoiesis with rh-CSF or rh IL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 1995; 16: 373-379.
10. Attarian H, Feng Z, Buckner C et al. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant 1996; 17: 425-430.
11. + selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting. Blood 1997; 90: 2830-2838.
12. al-Fiar F, Prince H, Stewart A et al. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of colony-forming unit granulocyte-macrophage (CFU-GM) assay. Cell Transpl 1997; 6: 491-495.
13. Kreissig C, Kirsh A. Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994; 3: 263-266.
14. Krause D, Fackler M, Civin C, May W. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
15. Baumann Y, Swindell R, Van Hoeff M et al. Mobilization kinetics of primitive haemopoietic cells following G-CSF with or without chemotherapy for advanced breast cancer. Ann Oncol 1996; 7: 1051-1057.
16. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
17. + cells: correlation to the quantitation of circulating hemopoietic progenitor cells by in vitro colony-assay. Br J Haematol 1991; 77: 453-459.
18. Sutherland H, Eaves C, Lansdorp P et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
19. Lewis I, Rawling T, Dyson P et al. Standardization of the CFU-GM assay using hematopoietic growth factors. J Hematother 1996; 6: 625-630.
20. Serke S, Arseniev L, Watts M et al. Imprecision of counting CFU-GM and CD34-expressing cells. Bone Marrow Transplant 1997; 20: 57-61.
21. Lumley M, Burgess R, Lillingham L et al. Colony counting is a major source of variation in CFU-GM results between centres. Br J Haematol 1997; 97: 481-484.
22. Kessinger A, Armitage J, Landmark J et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988; 71: 723-727.
23. To L. Haylock D, Thorp D et al. The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplant 1989; 4: 41-47.
24. Bender J, Bik To L, Williams S, Schwartzberg L. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-341.
25. Stahel R, Jost L, Cerny T et al. Randomized study of recombinant human granulocyte-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol 1994; 12: 1931-1938.
26. Lackey D, Hillyer C. Colony-forming unit culture of bone marrow and peripheral blood stem cells: comparison of commercially available media. J Hematother 1992; 1: 289-292.
27. Pettengell R, Woll P, O'Connor D et al. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplant 1994; 14: 703-709.
28. Feltz C, Miller G. An asymptotic test for the equality of coefficients of variation from k populations. Stat Med 1996; 15: 647-652.
29. + cell enumeration in blood and leukapheresis products: report from the second Nordic workshop. J Hematother 1996; 5: 237-245.
30. Lowdell M, Bainbridge D and participants of the Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes. External quality assurance for CD34 cell enumeration. Results of a preliminary national trial. Bone Marrow Transplant 1996; 17: 849-853.
31. + cell estimation in leucapheresis products. Bone Marrow Transplant 1996; 18: 791-796.
32. + hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 1997; 30: 109-117.
33. Chin-Yee Y, Anderson L, Keeney M, Sutherland D, and the Canadian QASE Study Group. Quality assurance of stem cell enumeration by flow cytometry. Cytometry 1997; 30: 296-303.